batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Imfinzi holds its own in bile duct cancer 16 April 2024 Tecvayli threatens to eclipse Carvykti 16 April 2024 Regeneron’s double-whammy, courtesy of Roche 15 April 2024 Bristol’s son of Revlimid goes pivotal 12 April 2024 AACR 2024 – indolent lymphoma presents fresh CD47 promise 11 April 2024 Arvinas degraders get another vote of confidence 11 April 2024 AACR 2024 – US accelerated approvals come under more fire 9 April 2024 Tracon’s subcutaneous hopes evaporate 5 April 2024 Load More